SodiumChloride

Phase 3Small molecule

RRadboud University Medical Center

SodiumChloride is one of 78 small molecule programs targeting Diabetic Ketoacidosis. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Diabetic KetoacidosisActive, not recruiting

DeliriumActive, not recruiting

HypoglycemiaActive, not recruiting

Diabetic KetoacidosisPreclinical

Active, not recruiting

DeliriumPhase 3

Active, not recruiting

HypoglycemiaPreclinical

Active, not recruiting

Competition

Competitive Landscape

167 competitors in Delirium

#DrugCompanyPhaseTrials

Neurontin

VViatris Specialty LLC

Phase 3

1 2

Lidocaine IV

KKasr El Aini Hospital

Phase 3

1 3

Physostigmine

AstraZeneca

Phase 3

1 4

SodiumChloride

RRadboud University Medical Center

Phase 3

1 5

Rozerem

Takeda

Preclinical

6 6

Inapsine

Alnylam Pharmaceuticals

Preclinical

1 7

Anerem

AAcacia Pharma Ltd

Preclinical

7 8

Spravato

WWim Janssens

Preclinical

4 9

Raldesy

PPragma

Preclinical

3 10

Bridion

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Hypoglycemia1 trial

The Effect of Intravenous Lactate on Brain Lactate Concentrations During Hypoglycemia

Completed·RRadboud University Medical Center·N/A·NCT03286816·19 enrolled

Delirium1 trial

The Effect of Clonidine-enhanced Sedation on Delirium in Ventilated Critically Ill Patients

Unknown status·DDeventer Ziekenhuis·Phase 3·NCT01876355·115 enrolled

Diabetic Ketoacidosis1 trial

Fluid Kinetics in Patients With Diabetic Ketoacidosis

Completed·UUniversity Hospital, Linkoeping·N/A·NCT02172092·17 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for SodiumChloride. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — SodiumChloride compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for SodiumChloride. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Radboud University Medical Center company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: RRadboud University Medical Center

SodiumChloride

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Hypoglycemia1 trial

Delirium1 trial

Diabetic Ketoacidosis1 trial

References

Drug Info

Quick Facts

Related News